[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100464436":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":10,"centralContacts":21,"locations":33,"responsibleParty":51,"collaborators":53,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":10,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":72,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de la Réunion","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"patients who accept Allogeneic Hematopoietic Stem Cell Transplantation (alloH SCT)",null,[12],"Other: questionnaire",{"label":14,"type":10,"description":10,"interventionNames":15},"patients who did not accept Allogeneic Hematopoietic Stem Cell Transplantation (alloH SCT)",[12],[17],{"type":6,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"questionnaire","* quality of life score: FACT-BMT\n* decisional conflict scale\n* Discreet Choice Experiment questionnaire",[9,14],[22,28],{"name":23,"role":24,"phone":25,"phoneExt":26,"email":27},"Lucie AUZANNEAU","CONTACT","0262359949","+262","lucie.auzanneau@chu-reunion.fr",{"name":29,"role":24,"phone":30,"phoneExt":31,"email":32},"Patricia MARINO","04.91.22.35.02","+33","patricia.marino@inserm.fr",[34],{"facility":35,"status":10,"city":36,"state":10,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"CHU de la Réunion","Saint-Pierre","97448","France","FR",{"type":41,"coordinates":42},"Point",[43,44],5.40682,43.29282,{"lat":44,"lon":43},[47,48],{"name":23,"role":24,"phone":10,"phoneExt":10,"email":27},{"name":49,"role":50,"phone":10,"phoneExt":10,"email":10},"Patricia ZUNIC, PH","PRINCIPAL_INVESTIGATOR",{"type":52,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[54],{"name":55,"class":6},"Institut Paoli-Calmettes","100464436","impact-of-the-use-of-allogeneic-hematopoietic-stem-cell-transplantation-in-reunion-island-patients-quality-of-life-determinants-of-choices-and-financial-repercussions-100464436",false,"NCT05327673","Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions","AlloRé","Inclusion Criteria:\n\n* patients diagnosed with hematological malignancy (myeloid acute leukemia, lymphoid acute leukemia, non-hodgkin lymphoma, Hodgkin disease, or myelodysplasic syndrome\n* candidate to an allogeneic hematopoietic stem cell transplantation in mainland France ;\n* Residing in Reunion Island\n* Age \\>18 year old;\n* who accept or not allogeneic hematopoietic\n* Able to complete a questionnaire\n\nExclusion Criteria:\n\n* Opposition to participation and collection of their data\n* Person deprived of liberty by judicial or administrative decision, and person subject to legal protection (guardianship or curators)","ALL","18 Years",{"count":66,"type":67},100,"ESTIMATED","OBSERVATIONAL","This project aims to document and analyse - with a three-fold anthropological, psychosocial and economical approach - the consequences of the geographical distance from mainland France on the alloSCT on both patients, their caregivers and the healthcare system. It is organised in 3 working packages (WP).",[71],"Allogeneic Hematopoietic Stem Cell Transplantation","NOT_YET_RECRUITING","2022-04-14",{"date":75,"type":76},"2022-04-21","ACTUAL",{"date":78,"type":67},"2022-07",{"date":80,"type":67},"2027-03",{"name":5,"class":6},1]